Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes
2012
Prevalence and role of serum IgE antibodies to the StaphylococcuS aureus–derived superantigens SEA and SEB in children with atopic dermatitis
1999
High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial
1998
Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism
2000
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data
2009
Skin diseases associated with Malassezia species
2004
Atopic Dermatitis
2008 Standout
New drugs in melanoma: It’s a whole new world
2011
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
2003
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
2017 StandoutNobel
IL-1 and Allergy
2010
Psoriasis
2009 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Atopic dermatitis
2003 Standout
Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma
2008
Pathogenesis and clinical features of psoriasis
2007 Standout
The T cell response against fungal infections
1997
Ovarian cancer
2014 Standout
Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review
2008
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Atopic dermatitis
2015 Standout
Role of Bacterial Superantigens in Atopic Dermatitis
2006
The application and challenges of clinical PD–PDT in the head and neck region: A short review
2010
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Psoriasis
2021 Standout
The skin microbiome
2011 Standout
Lysogenic Transfer of Group AStreptococcusSuperantigen Gene among Streptococci
2008 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial
2011
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The development of allergic inflammation
2008 StandoutNature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
2000
Advances in systemic treatment of melanoma
2010
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis
2009
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Expression of mRNA for Interferon-Gamma, Interleukin-10, and Interleukin-12 (p40) in Normal Gastric Mucosa and in Mucosa Infected withHelicobacter pylori
1997
Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis
2001
Identification of superantigen genesspeM,ssa, andsmeZin invasive strains of beta-hemolytic group C and G streptococci recovered from humans
2003
Therapy of Cutaneous Lymphoma – Current Practice and Future Developments
2003
Cancer immunotherapy comes of age
2011 StandoutNature
Management of Metastatic Melanoma 2005
2006
Atherosclerosis — An Inflammatory Disease
1999 Standout
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
2002
Evidence for Superantigen Involvement in Skin Homing of T cells in Atopic Dermatitis
1999
Photodynamic therapy of cancer: An update
2011 Standout
Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a north american series
2003
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders
2001
Platelet Activation During Allergic Inflammation
2007
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
2012
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
2004
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Does “autoreactivity” play a role in atopic dermatitis?
2012
Immunity to fungal infections
2011 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study
2003
Neutrophil recruitment and function in health and inflammation
2013 Standout
The role of microorganisms in atopic dermatitis
2006
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
2010
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
2003
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
Leukotriene B4-Driven Neutrophil Recruitment to the Skin Is Essential for Allergic Skin Inflammation
2012
The immunopathogenesis of sepsis
2002 StandoutNature
The role of Malassezia in atopic dermatitis affecting the head and neck of adults
2008
Oxidative Stress in Atopic Dermatitis
2016
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review)
2010
Atopic Dermatitis and Fungi
2002
Possible influences of Staphylococcus aureus on atopic dermatitis — the colonizing features and the effects of staphylococcal enterotoxins
1999
Azole-Based Energetic Salts
2011 Standout
Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris
2002
Resident memory T cells in human health and disease
2015
IL-17 and Th17 Cells
2009 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenesSuperantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A
2001
Inflammation and Atherosclerosis
2002 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and Pathophysiology
2003 Standout
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
2017
Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group
2006
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma
2009
Modified T‐cell activation pattern during specific immunotherapy (SIT) in cat‐allergic patients
1999
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
2009
An Assessment of the Role of Candida albicans Antigen in Atopic Dermatitis
1999
Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
2009
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases
1997
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
2011
Emerging Targets in Photopharmacology
2016 StandoutNobel
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
2003
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
2005
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
2011
Prolonged effects of antidandruff shampoos ‐ time to recurrence of Malassezia ovalis colonization of skin
1997
Antiinflammatory Properties of HDL
2004 Standout
Endothelial Function and Dysfunction
2007 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of K. Neuber being referenced
In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group
2006
Preferential expression of T-cell receptor V beta-chains in atopic eczema.
1996
Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema
2001
Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self‐adhesive 5‐aminolaevulinic acid patch
2008
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a
1998
Staphylococcal Enterotoxin B Affects in vitro IgE Synthesis, Interferon-γ, lnterleukin-4 and lnterleukin-5 Production in Atopic Eczema
1995
Decreased monocyte inter leukin-1ss production in atopic eczema
1995
Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan
2003
Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
1996
Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema.
1995
Differential Increase in 12-HETE Release and CD29/CD49f Expression of Platelets from Normal Donors and from Patients with Atopic Dermatitis by <i>Staphylococcus aureus</i>
1992
Elevated Serum Levels of Soluble Adhesion Molecules ICAM-1 and ELAM-1 in Patients with Severe Atopic Eczema and Influence of UVA1 Treatment
1995
Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis
1994
Atopic eczema: role of microorganisms on the skin surface
1992
Responsiveness of Peripheral Blood Mononuclear Cells from Normal and Atopic Donors to Microbial Superantigens
1995
Treatment of atopic eczema with oral mycophenolate mofetil
2000
Telomere length measurement and determination of immunosenescence‐related markers (CD28, CD45RO, CD45RA, interferon‐γ and interleukin‐4) in skin‐homing T cells expressing the cutaneous lymphocyte antigen: indication of a non‐ageing T‐cell subset
2003
Low dose versus medium dose UV-A1 treatment in severe atopic eczema.
1995
Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo
1999
Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study
2004
Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis.
1992
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
2000
Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis.
1991
Effects ofPityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFNγ) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis
1996
Autoantibodies against CD28 are associated with atopic diseases
2006
Reduction of tumor burden and stabilization of disease by systemic therapy with anti‐CD20 antibody (rituximab) in patients with primary cutaneous B‐cell lymphoma
2000
Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)
2002